165 related articles for article (PubMed ID: 32188269)
1. The potential of circulating exosomal RNA biomarkers in cancer.
Chu YL; Li H; Ng PLA; Kong ST; Zhang H; Lin Y; Tai WCS; Yu ACS; Yim AKY; Tsang HF; Cho WCS; Wong SCC
Expert Rev Mol Diagn; 2020 Jul; 20(7):665-678. PubMed ID: 32188269
[TBL] [Abstract][Full Text] [Related]
2. An Immuno-Biochip Selectively Captures Tumor-Derived Exosomes and Detects Exosomal RNAs for Cancer Diagnosis.
Yang Y; Kannisto E; Yu G; Reid ME; Patnaik SK; Wu Y
ACS Appl Mater Interfaces; 2018 Dec; 10(50):43375-43386. PubMed ID: 30451486
[TBL] [Abstract][Full Text] [Related]
3. Tandem enrichment of serum exosomes and exosomal RNA with titanium dioxide.
Zhang B; Li H; Kong L; Yang N; Yang S; Qi L; Liu T; Wang X; Qin W
J Chromatogr A; 2023 Mar; 1693():463882. PubMed ID: 36857982
[TBL] [Abstract][Full Text] [Related]
4. Polyethylene Glycol -Mediated Exosome Isolation: A Method for Exosomal RNA Analysis.
Teflischi Gharavi A; Niknejad A; Irian S; Rahimi A; Salimi M
Iran Biomed J; 2024 Mar; 28(2&3):132-9. PubMed ID: 38468372
[TBL] [Abstract][Full Text] [Related]
5. Integrated isolation and quantitative analysis of exosome shuttled proteins and nucleic acids using immunocapture approaches.
Zarovni N; Corrado A; Guazzi P; Zocco D; Lari E; Radano G; Muhhina J; Fondelli C; Gavrilova J; Chiesi A
Methods; 2015 Oct; 87():46-58. PubMed ID: 26044649
[TBL] [Abstract][Full Text] [Related]
6. Comparison of isolation methods of exosomes and exosomal RNA from cell culture medium and serum.
Tang YT; Huang YY; Zheng L; Qin SH; Xu XP; An TX; Xu Y; Wu YS; Hu XM; Ping BH; Wang Q
Int J Mol Med; 2017 Sep; 40(3):834-844. PubMed ID: 28737826
[TBL] [Abstract][Full Text] [Related]
7. Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in
Peng XX; Yu R; Wu X; Wu SY; Pi C; Chen ZH; Zhang XC; Gao CY; Shao YW; Liu L; Wu YL; Zhou Q
J Immunother Cancer; 2020 Jan; 8(1):. PubMed ID: 31959728
[TBL] [Abstract][Full Text] [Related]
8. Liquid Biopsy beyond Circulating Tumor Cells and Cell-Free DNA.
Junqueira-Neto S; Batista IA; Costa JL; Melo SA
Acta Cytol; 2019; 63(6):479-488. PubMed ID: 30783027
[TBL] [Abstract][Full Text] [Related]
9. Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma.
Lee YR; Kim G; Tak WY; Jang SY; Kweon YO; Park JG; Lee HW; Han YS; Chun JM; Park SY; Hur K
Int J Cancer; 2019 Mar; 144(6):1444-1452. PubMed ID: 30338850
[TBL] [Abstract][Full Text] [Related]
10. Exosomal piRNA profiling revealed unique circulating piRNA signatures of cholangiocarcinoma and gallbladder carcinoma.
Gu X; Wang C; Deng H; Qing C; Liu R; Liu S; Xue X
Acta Biochim Biophys Sin (Shanghai); 2020 May; 52(5):475-484. PubMed ID: 32369104
[TBL] [Abstract][Full Text] [Related]
11. Profiling cell-free and circulating miRNA: a clinical diagnostic tool for different cancers.
Chakraborty C; Das S
Tumour Biol; 2016 May; 37(5):5705-14. PubMed ID: 26831657
[TBL] [Abstract][Full Text] [Related]
12. Circulating Exosomal Gastric Cancer-Associated Long Noncoding RNA1 as a Biomarker for Early Detection and Monitoring Progression of Gastric Cancer: A Multiphase Study.
Guo X; Lv X; Ru Y; Zhou F; Wang N; Xi H; Zhang K; Li J; Chang R; Xie T; Wang X; Li B; Chen Y; Yang Y; Chen L; Chen L
JAMA Surg; 2020 Jul; 155(7):572-579. PubMed ID: 32520332
[TBL] [Abstract][Full Text] [Related]
13. An optimized procedure for exosome isolation and analysis using serum samples: Application to cancer biomarker discovery.
Li M; Rai AJ; DeCastro GJ; Zeringer E; Barta T; Magdaleno S; Setterquist R; Vlassov AV
Methods; 2015 Oct; 87():26-30. PubMed ID: 25814440
[TBL] [Abstract][Full Text] [Related]
14. Integrative analysis of long extracellular RNAs reveals a detection panel of noncoding RNAs for liver cancer.
Zhu Y; Wang S; Xi X; Zhang M; Liu X; Tang W; Cai P; Xing S; Bao P; Jin Y; Zhao W; Chen Y; Zhao H; Jia X; Lu S; Lu Y; Chen L; Yin J; Lu ZJ
Theranostics; 2021; 11(1):181-193. PubMed ID: 33391469
[No Abstract] [Full Text] [Related]
15. Circulating microRNAs as biomarkers in cancer diagnosis.
Sohel MMH
Life Sci; 2020 May; 248():117473. PubMed ID: 32114007
[TBL] [Abstract][Full Text] [Related]
16. Quantification of MicroRNAs in Urine-Derived Specimens.
Fuessel S; Lohse-Fischer A; Vu Van D; Salomo K; Erdmann K; Wirth MP
Methods Mol Biol; 2018; 1655():201-226. PubMed ID: 28889388
[TBL] [Abstract][Full Text] [Related]
17. Advances of exosome isolation techniques in lung cancer.
Mahgoub EO; Razmara E; Bitaraf A; Norouzi FS; Montazeri M; Behzadi-Andouhjerdi R; Falahati M; Cheng K; Haik Y; Hasan A; Babashah S
Mol Biol Rep; 2020 Sep; 47(9):7229-7251. PubMed ID: 32789576
[TBL] [Abstract][Full Text] [Related]
18. The potential of circulating cell free RNA as a biomarker in cancer.
Cheung KWE; Choi SR; Lee LTC; Lee NLE; Tsang HF; Cheng YT; Cho WCS; Wong EYL; Wong SCC
Expert Rev Mol Diagn; 2019 Jul; 19(7):579-590. PubMed ID: 31215265
[No Abstract] [Full Text] [Related]
19. Integrated systems for exosome investigation.
Peterson MF; Otoc N; Sethi JK; Gupta A; Antes TJ
Methods; 2015 Oct; 87():31-45. PubMed ID: 25916618
[TBL] [Abstract][Full Text] [Related]
20. Serum exosomal microRNAs as novel biomarkers for multiple myeloma.
Zhang ZY; Li YC; Geng CY; Zhou HX; Gao W; Chen WM
Hematol Oncol; 2019 Oct; 37(4):409-417. PubMed ID: 31102419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
